{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:00:25Z","timestamp":1793714425101,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1U10EY023558-01A1"],"award-info":[{"award-number":["1U10EY023558-01A1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1U10EY024247-01"],"award-info":[{"award-number":["1U10EY024247-01"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015195","name":"Applied Genetic Technologies Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajo.2023.09.005","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:36:47Z","timestamp":1694738207000},"page":"113-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Leber Hereditary Optic Neuropathy Gene Therapy: Longitudinal Relationships Among Visual Function and Anatomical Measures"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-2366","authenticated-orcid":false,"given":"Byron L.","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Feuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Porciatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Diane","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Vanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonore J.","family":"Savatovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego E.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2023.09.005_bib0001","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/118.2.319","article-title":"The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation","volume":"118","author":"Riordan-Eva","year":"1995","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.005_bib0002","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11940-010-0100-y","article-title":"Leber's hereditary optic neuropathy","volume":"13","author":"Sadun","year":"2011","journal-title":"Curr Treat Options Neurol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.005_bib0003","first-page":"77","article-title":"Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation","volume":"57","author":"Harding","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.005_bib0004","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamaophthalmol.2013.7971","article-title":"Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy: preparation for gene therapy clinical trial","volume":"132","author":"Lam","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.005_bib0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ajo.2022.02.023","article-title":"Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups","volume":"241","author":"Lam","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.005_bib0006","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0962-8924(91)90037-A","article-title":"Protein import into mitochondria: two systems acting in tandem?","volume":"1","author":"Glick","year":"1991","journal-title":"Trends Cell Biol"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.005_bib0007","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/ng851","article-title":"Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus","volume":"30","author":"Manfredi","year":"2002","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.005_bib0008","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1146\/annurev.biochem.66.1.863","article-title":"Protein import into mitochondria","volume":"66","author":"Neupert","year":"1997","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.005_bib0009","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene therapy for Leber hereditary optic neuropathy: initial results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.11.3.31","article-title":"The relationship between stage of Leber's hereditary optic neuropathy and pattern electroretinogram latency","volume":"11","author":"Porciatti","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.005_bib0011","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ophtha.2003.04.007","article-title":"Normative data for a user-friendly paradigm for pattern electroretinogram recording","volume":"111","author":"Porciatti","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.09.005_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10633-012-9353-y","article-title":"ISCEV standard for clinical pattern electroretinography (PERG): 2012 update","volume":"126","author":"Bach","year":"2013","journal-title":"Document Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.09.005_bib0013","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1167\/iovs.14-15685","article-title":"Relationship between transient and steady-state pattern electroretinograms: theoretical and experimental assessment","volume":"55","author":"\u00d6zdamar","year":"2014","journal-title":"Invest Ophthal Vis Science"},{"key":"10.1016\/j.ajo.2023.09.005_bib0014","article-title":"Pattern electroretinogram in ocular hypertension, glaucoma suspect and early manifest glaucoma eyes: a systematic review and meta-analysis","author":"Afflitto","year":"2023","journal-title":"Ophthalmol Sci"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.6.3.5","article-title":"Next generation PERG method: expanding the response dynamic range and capturing response adaptation","volume":"6","author":"Monsalve","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"11","key":"10.1016\/j.ajo.2023.09.005_bib0016","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1167\/iovs.11-7896","article-title":"Profile and predictors of normal ganglion cell\u2013inner plexiform layer thickness measured with frequency-domain optical coherence tomography","volume":"52","author":"Mwanza","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.005_bib0017","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ophtha.2004.07.018","article-title":"Pattern electroretinogram abnormality and glaucoma","volume":"112","author":"Ventura","year":"2005","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2023.09.005_bib0018","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.3390\/ijms23105751","article-title":"Using noninvasive electrophysiology to determine time windows of neuroprotection in optic neuropathies","volume":"23","author":"Porciatti","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.005_bib0019","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WNO.0000000000001045","article-title":"Visual outcomes in Leber hereditary optic neuropathy patients with the m. 11778G>A (MTND4) mitochondrial DNA mutation","volume":"40","author":"Newman","year":"2020","journal-title":"J Neuroophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.09.005_bib0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ophtha.2020.12.012","article-title":"Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset","volume":"128","author":"Newman","year":"2021","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.005_bib0021","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1093\/brain\/awac421","article-title":"Randomized trial of bilateral gene therapy injection for m. 11778G>A MT-ND4 Leber optic neuropathy","volume":"146","author":"Newman","year":"2023","journal-title":"Brain"},{"issue":"573","key":"10.1016\/j.ajo.2023.09.005_bib0022","doi-asserted-by":"crossref","first-page":"eaaz7423","DOI":"10.1126\/scitranslmed.aaz7423","article-title":"Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy","volume":"12","author":"Yu-Wai-Man","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajo.2023.09.005_bib0023","first-page":"401","article-title":"Indirect comparison of lenadogene nolparvovec gene therapy versus natural history in patients with Leber hereditary optic neuropathy carrying the m. 11778G>A MT-ND4 mutation","author":"Carelli","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"40","key":"10.1016\/j.ajo.2023.09.005_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005110","article-title":"Evaluation of Leber's hereditary optic neuropathy patients prior to a gene therapy clinical trial","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.005_bib0025","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41433-021-01535-9","article-title":"Natural history of patients with Leber hereditary optic neuropathy\u2014results from the REALITY study","volume":"36","author":"Yu-Wai-Man","year":"2022","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.005_bib0026","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/archopht.116.2.227","article-title":"Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons","volume":"116","author":"Mangione","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.005_bib0027","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/WNO.0000000000000644","article-title":"Evaluation of vision-related quality of life in Chinese patients with Leber hereditary optic neuropathy and the G11778A mutation","volume":"39","author":"Cui","year":"2019","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2023.09.005_bib0028","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/OPTH.S113414","article-title":"Profound vision loss impairs psychological well-being in young and middle-aged individuals","volume":"11","author":"Garcia","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.09.005_bib0029","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1167\/iovs.08-3166","article-title":"Quality of life in patients with Leber hereditary optic neuropathy","volume":"50","author":"Kirkman","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.005_bib0030","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","article-title":"Long-term follow-up after unilateral intravitreal gene therapy for Leber hereditary optic neuropathy: the RESTORE study","volume":"41","author":"Biousse","year":"2021","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2023.09.005_bib0031","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.omtm.2021.09.013","article-title":"Biodistribution of intravitreal lenadogene nolparvovec gene therapy in nonhuman primates","volume":"23","author":"Calkins","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.ajo.2023.09.005_bib0032","first-page":"1","article-title":"Electrophysiological and structural changes in Chinese patients with LHON","volume":"2020","author":"Wang","year":"2020","journal-title":"J Ophthalmol"},{"issue":"241","key":"10.1016\/j.ajo.2023.09.005_bib0033","doi-asserted-by":"crossref","first-page":"A11","DOI":"10.1016\/j.ajo.2022.05.018","article-title":"Gene therapy for Leber's hereditary optic neuropathy: time to include a true placebo arm?","author":"Wang","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.09.005_bib0034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-022-01246-y","article-title":"Developments in the treatment of Leber hereditary optic neuropathy","volume":"22","author":"Chen","year":"2022","journal-title":"Curr Neurol Neurosci Rep"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423003628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423003628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:32:43Z","timestamp":1778646763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423003628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":34,"alternative-id":["S0002939423003628"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.09.005","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leber Hereditary Optic Neuropathy Gene Therapy: Longitudinal Relationships Among Visual Function and Anatomical Measures","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}